Aemetis Inc. (NASDAQ:AMTX) finished Wednesday with an addition of $0.03 to close at $21.18, an upside of 0.14 percent. An average of 1,370,460 shares of common stock have been traded in the last five days. There was a gain of $3.78 in the past week. The last 20 days have seen an average of 1,492,640 shares traded, while the 50-day average volume stands at 1,099,264.
AMTX stock has increased by 62.55% in the last month. The company shares reached their 1-month lowest point of $12.71 on 09/20/21. With the stock rallying to its 52-week high on 03/24/21, shares of the company touched a low of $1.96 and a high of $27.44 in 52 weeks. In spite of this, the price is down -22.81% from the 52-week high.
3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
28 days have passed since Aemetis Inc. (AMTX) last reported insider trading activity. Gupta Sanjeev, who is Executive Vice President, MD, most recently acquired $124,500 shares at $14.37 per share on Sep 16. In this transaction, the insider spent $1,789,351. Director, BLOCK JOHN R, disposed of 14,511 shares at a price of $13.94 on Sep 16. The insider now owns more than $202,259 worth of shares. Prior to that, Executive Vice President, MD Gupta Sanjeev went on to Sale 50,000 shares at $14.25 each on Sep 15. An amount of $712,500 was transacted.
Aemetis Inc. (AMTX) has a trailing price-to-earnings (P/E) ratio of 18.90 for the broader industry and 19.70 for the sector. The stock’s beta is -0.33. Other valuation ratios to consider include the trailing price-to-sales (P/S) ratio at 3.81.
The quick ratio of Aemetis Inc. for the three months ended June 29 was 0.20, and the current ratio was 0.30, indicating that the company is not able to meet its debt obligations. On the profitability front, the trailing 12-month gross margin is -1.50% against a 5-year average of 5.3%. Aemetis Inc.’s EBITDA margin for the year ending June 29 is -0.50%, while its operating margin for the same period stands at -12.30%. Its gross profit as reported stood at $11.03 million compared to revenue of $165.56 million.
For investors, determining the potential profitability of the investment also depends on the performance of the company’s management. In the past 12 months, Aemetis Inc.’s return on assets was -41.50%, compared to -32.0% over the last five years.
The analyst consensus anticipated Aemetis Inc.’s latest quarter earnings to come in at -$0.46 per share, but it turned out to be -$0.34, a 26.10% surprise. For the quarter, EBITDA amounted to $48000.0. Shareholders own equity worth $31.69 million.
From a technical analysis perspective, let’s take a brief look at Aemetis Inc. (AMTX) price momentum. RSI 9-day as of the close on 13 October was 73.11%, suggesting the stock is Overbought, with historical volatility in this time frame at 119.01%.
As of today, AMTX’s price is $20.30 +21.72% or $3.78 from its 5-day moving average. AMTX is currently trading +49.26% higher than its 20-day SMA and +89.78% higher than its 100-day SMA. However, the stock’s current price level is +135.60% above the SMA50 and +653.74% above the SMA200.
The stochastic %K and %D were 91.76% and 91.02%, respectively, and the average true range (ATR) was 1.64. With the 14-day stochastic at 92.69% and the average true range at 1.54, the RSI (14) stands at 71.11%. The stock has reached 1.79 on the 9-day MACD Oscillator while the 14-day reading was at 2.78.
Evercore ISI launched coverage on Aemetis Inc. (NASDAQ: AMTX) in its analyst report released on July 15, 2021. The firm assigned the stock a an Outperform rating.The consensus rating for Aemetis Inc. (AMTX) among analysts is Buy. According to current brokerage recommendations, 0 brokerage firms advise that investors sell AMTX, while 0 suggest investors hold. There are 0 analysts who rate the stock as underweight. The stock is rated overweight by 0 analysts, while 6 others rate it as a “buy”.
What is AMTX’s price target for the next 12 months?
Analysts predict a range of price targets between $25.00 and $35.00, with a median target of $32.00. Taking a look at these predictions, the average price target given by analysts for Aemetis Inc. (AMTX) stock is $30.83.